| References |
Product citationsHan, Z.; Li, Y.; Roelle, S.; Zhou, Z.; Liu, Y.; Sabatelle, R.; DeSanto, A.; Yu, X.; Zhu, H.; Magi-Galluzzi, C.; Lu, Z.-R. A Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI. Bioconjugate Chemistry, in press. doi: 10.1021/acs.bioconjchem.6b00719 Balasso, A.; Salmaso, S.; Pontisso, P.; Rosato, A.; Quarta, S.; Malfanti, A.; Mastrotto, F.; Caliceti, P. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences, in press. doi: 10.1016/j.ejps.2017.02.016 Han, S.; Son, H.Y.; Kang, B.; Jang, E.; Ki, J.; Lee, N.G.; Park, J.; Shin, M.-K.; Mun, B.; Min, J.-K.; Haam, S. Fluorescent nanoswitch for monitoring specific pluripotency-related microRNAs of induced pluripotent stem cells: Development of polyethyleneimineoligonucleotide hybridization probes. Nano Research, in press. doi: 10.1007/s12274-016-1403-4 Sun, W.; Li, L.; Yang, Q.-Q.; Zhang, Z.-R.; Huang, Y. Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12. Acta Pharmacologica Sinica, in press. doi: 10.1038/aps.2016.137
|
